Abstract: To realize a vertical type wireless charging device capable of detecting a metal foreign object. The wireless charging device comprises a holder, a power transmission coil, a thermal sensor, a controller, and a warning device. The power transmission coil is disposed outside the side part of the holder. The thermal sensor is disposed at the bottom part of the holder. When the temperature rising rate is not less than 20° C. per five minutes, the controller judges that a metal foreign object exists between the power transmission coil and the electronic device, and the foreign object generates unusual heat. The controller stops wireless charging from the power transmission coil to the electronic device. The controller starts the warning device to alert the user that a foreign object is mixed in the holder and generates unusual heat.

Abstract: To realize a vertical type wireless charging device capable of detecting a metal foreign object. The wireless charging device comprises a holder, a power transmission coil, a thermal sensor, a controller, and a warning device. The power transmission coil is disposed outside the side part of the holder. The thermal sensor is disposed at the bottom part of the holder. When the temperature rising rate is not less than 20° C. per five minutes, the controller judges that a metal foreign object exists between the power transmission coil and the electronic device, and the foreign object generates unusual heat. The controller stops wireless charging from the power transmission coil to the electronic device. The controller starts the warning device to alert the user that a foreign object is mixed in the holder and generates unusual heat.

Abstract: A first conversion unit (201) converts a signal from a time domain to a frequency domain. A signal extraction unit (202) extracts common channel information included in the signal which has been converted by the first conversion unit (201). A signal substitution unit (207) restores the common channel information which has been extracted by the signal extraction unit (202). An addition unit (208) substitutes the common channel information which has been restored by the signal substitution unit (207) for the common channel information included in the signal which has been converted by the first conversion unit (201). A second conversion unit (209) converts the signal including the common channel information substituted, which has been converted by the first conversion unit (201), from the frequency domain to the time domain.

Abstract: Provided is a communication capacity evaluating apparatus whereby the communication capacity can be grasped and the necessity of changing the content of a dead spot measure after the placement of a relay apparatus can be eliminated. In the communication capacity evaluating apparatus, a system information analyzing unit (121) acquires, from a received signal, used-band information of the communication using a MIMO mode. An S/N calculating unit (122) analyzes the received signal to determine a signal-to-noise ratio. A channel estimating unit (123) analyzes the received signal to determine a channel matrix. A throughput limit calculating unit (124) calculates the limit value of the communication capacity on the basis of the used-band information, information about the number of transmission antennas of a base station (180), information about the number of reception antennas of a radio relay apparatus (100) stored in advance, the signal-to-noise ratio and the channel matrix.

Abstract: A product, comprising a reconfigurable toy assembly, said assembly being reversibly reconfigurable between at least a first configuration and a second configuration; and the toy including at least one body surface with an integral thermochromic layer covering at least a portion of the body, where the integral thermochromic layer exhibits a visual change in response to temperature is provided.

Abstract: An objective of the present invention is to provide methods for selecting candidate peptides presented on the surface of cancer cells following binding to MHC class I molecules, wherein the peptides are involved in the stimulation of T cell immunity (cellular immunity). The present inventors discovered a new principle of MHC I-mediated antigen presentation in which a T cell antigen epitope is more efficiently presented on MHC I molecules when it is positioned at the N-terminal side than when positioned at the C-terminal side.

Abstract: The present inventors worked on elucidating the mechanism of antigen cross-presentation by dendritic cells, and revealed that foreign antigens taken up in dendritic cells are degraded by proteasomes after undergoing polyubiquitination. Based on the novel finding that polyubiquitination is involved in cross-presentation, the promotion of polyubiquitination was attempted by a number of methods, and the promotion of antigen presentation was confirmed. These methods enable the production of dendritic cells effective for inducing CTL activation.

Abstract: The present inventors worked on elucidating the mechanism of antigen cross-presentation by dendritic cells, and revealed that foreign antigens taken up in dendritic cells are degraded by proteasomes after undergoing polyubiquitination. They discovered a positive correlation between the uptake amount of an antigenic protein by dendritic cells or the level of polyubiquitination and the level of antigen presentation of the antigenic protein. Based on these findings, methods were developed for predicting the intensity of cross-presentation of an anti genic protein by measuring the amount of antigenic protein taken up or polyubiquitinated protein. The use of these methods allows selecting antigenic proteins that are readily presented as antigens from among a number of proteins. The methods of the present invention enable suitable cancer immune vaccines to be provided through selection of more suitable cancer-specific proteins.

Abstract: A product, comprising a reconfigurable toy assembly, said assembly being reversibly reconfigurable between at least a first configuration and a second configuration; and the toy including at least one body surface with an integral thermochromic layer covering at least a portion of the body, where the integral thermochromic layer exhibits a visual change in response to temperature is provided.

Abstract: A product, comprising a toy; and the toy including a thermochromic region on at least a portion of the toy, where the thermochromic region exhibits a visual change in response to temperature; a code, wherein the thermochromic region reveals a human readable code upon the visual change; and a decoder for decoding the code is provided.

Abstract: A molding condition optimizing system for an injection molding machine comprising plastic flow condition optimizing section and an operating condition determining section is disclosed. The plastic flow condition optimizing section carries out a plastic flow analysis on a molded part model, and determines an optimum flow condition in a filling stage and a packing stage of an injection molding process of the injection molding machine by repeatedly executing an automated calculation using the result of the plastic flow analysis and the plastic flow analysis itself.

Abstract: A petroleum additive having excellent storage stability and heat stability, which comprises an alkaline earth metal salt of aromatic hydroxycarboxylic acid containing a higher aliphatic carboxylic acid, a higher aliphatic amine or a higher aliphatic amide, or a sulfurized mixture thereof. A process for improving storage stability, heat stability and viscosity character of the petroleum additive.

Abstract: A transdermal absorptive drug formulation containing 3-isobutyryl-2-isopropylpyrazolo [1,5-a ]pyridine as active ingredient effective for bronchial asthma and cerebrovascular disorder is provided. The formulation affords excellent sustained releasing and long acting characteristics with substantially reduced side-effects such as nausea and vomitting.

Abstract: A therapeutic pharmaceutical composition containing 3,4,5-trimethoxy-N-3-piperidylbenzamide (troxipide) as an active ingredient for gastritis in admixture with an inert pharmaceutical carrier. The composition may be administered orally in the forms of tablets, capsules, granules and fine granules.

Abstract: Freeze-dried pharmaceutical preparation containing antibacterial quinolinecarboxylic acid derivatives are provided. These preparations are characterized by their stability against light and heat and have rapid solubility.

Abstract: A controlled-release pharmaceutical preparation of 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. The controlled-release preparation is in the form of powder or granule containing 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine, coated with medically non-active substance or in the form of rectal suppository containing 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. Further the controlled-release is prepared by implanting 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine in fatty materials, or granulating it and coating the resultant particles with medically non-active substance.

Abstract: A process for producing a liquefied coal oil by a two step hydrogenation reaction of coal, which comprises subjecting coal to a first hydrogenation and subjecting at least a part of the reaction product of the first hydrogenation to a second hydrogenation, wherein the second hydrogenation is conducted in the presence of an alkali metal compound and/or an alkaline earth metal compound and a catalyst carrying a metal of Group VI-A and a metal of Group VIII of the Periodic Table.